Advancing risk-based auditing one step further by identifying the underlying process deficiencies to enable improved corrective and preventive actions.
Kristel Van de Voorde
Advertisement
Vice President, Clinical Trial System and Auditing QA, RDQ, Bristol Myers Squibb
Articles by Kristel Van de Voorde
Advertisement
Latest Updated Articles
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
